Leifras Continues to Operate Nagoya City's Nagoya Club Activities Human Resources Bank, Addressing Instructor Shortage
Press Release

Leifras Continues to Operate Nagoya City's Nagoya Club Activities Human Resources Bank, Addressing Instructor Shortage

Three-Year Contract — Platform Supporting Elementary Schools’ "New Sports and Cultural Activities" TOKYO, Sept. 9, 2026 /PRNewswire/ — LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community engagement, and a leading operator of children’s sports schools and school club activity support businesses in […]

Read More
Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [²²⁵Ac]Ac-FL-261 Phase 1 Clinical Trial
Press Release

Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [²²⁵Ac]Ac-FL-261 Phase 1 Clinical Trial

LONDON, Sept. 9, 2026 /PRNewswire/ — Full-Life Technologies ("Full-Life", the "Company"), a privately held, fully integrated, clinical-stage actinium-based global radiopharmaceutical company, today announced that the U.S. Food and Drug Administration ("FDA") has cleared the Company’s Investigational New Drug ("IND") application for [225Ac]Ac-FL-261 and that the program has received Australian Human Research Ethics Committee ("HREC") approval and […]

Read More
SuperX Announces an Update on the Progress of Share Repurchases Program, to Demonstrate Confidence in Long-Term Growth Value
Press Release

SuperX Announces an Update on the Progress of Share Repurchases Program, to Demonstrate Confidence in Long-Term Growth Value

SINGAPORE, Sept. 9, 2026 /PRNewswire/ — SuperX AI Technology Limited (NASDAQ: SUPX) ("SuperX" or the "Company"), a Nasdaq-listed full-stack AI infrastructure solutions provider, today announced an update on the progress of its share repurchase program, demonstrating the Board’s and management’s confidence in the Company’s intrinsic value and long-term growth prospects. The Company’s Board of Directors authorized […]

Read More
Sceye's Stratospheric Platform Re-enters United States After Record-Breaking Roundtrip Stratospheric Flight Between U.S. and Japan
Press Release

Sceye's Stratospheric Platform Re-enters United States After Record-Breaking Roundtrip Stratospheric Flight Between U.S. and Japan

The journey, which lasted 30 days and traversed nearly 30,000 km, included operating for a week in the stratosphere over Japan. While over Japan, Sceye and its partner SoftBank Corp. successfully verified Direct-to-Device connectivity to unmodified devices, HAPS-based communications with drones, and edge computing from the stratosphere. MORIARTY, N.M., Sept. 9, 2026 /PRNewswire/ — Sceye, […]

Read More
Hyper3D Launches WorldGen to Turn Single Images into Editable 3D Scenes
Press Release

Hyper3D Launches WorldGen to Turn Single Images into Editable 3D Scenes

The Hyper3D world-generation model expands AI 3D generation from individual objects to complete scenes, combining individual 3D assets, spatial relationships and estimated physical properties for robotics simulation, filmmaking, game development and spatial computing. LOS ANGELES, Sept. 9, 2026 /PRNewswire/ — Hyper3D, an internationally leading 3D generative AI company, recently announced the launch of WorldGen, a world-generation […]

Read More
BEYOND THE CANVAS: JEFF KOONS REIMAGINES TIME WITH HUBLOT
Press Release

BEYOND THE CANVAS: JEFF KOONS REIMAGINES TIME WITH HUBLOT

NYON, Switzerland, Sept. 9, 2026 /PRNewswire/ — Hublot proudly announces an extraordinary collaboration with world-renowned artist Jeff Koons. A partnership made to take shape. Both Koons and Hublot operate on the same principle: transforming tension into form; contradiction into harmony; excess into precision. What appears playful is meticulously engineered. What feels effortless is the result […]

Read More
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer
Press Release

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept. 9, 2026 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, […]

Read More
SK keyfoundry Expands Collaboration with Elmos on 130nm Technology and Signs Long-Term Wafer Supply Agreement
Press Release

SK keyfoundry Expands Collaboration with Elmos on 130nm Technology and Signs Long-Term Wafer Supply Agreement

SEOUL, South Korea, Sept. 9, 2026 /PRNewswire/ — SK keyfoundry, an 8-inch pure-play foundry in Korea, announced that it has recently signed an agreement with Elmos Semiconductor SE (hereafter referred to as Elmos), a leading global supplier of mixed-signal semiconductors for the automotive industry, to expand their collaboration on 130nm technology and secure a long-term […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.